Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Newly Available Treatment Option for Inflammation After Cataract Surgery

Eric D. Donnenfeld, MD, joins Neda Shamie, MD, to discuss the results of a phase 3 multicenter study of IBI-10090 anterior chamber dexamethasone drug-delivery suspension (Dexycu, EyePoint Pharmaceuticals). How did this agent compare to prednisolone acetate 1.0% ophthalmic drops for treating inflammation after cataract surgery?

Cataract Surgery • Inflammation


1 / 29 Series: Clinical Minute


More Videos in this Series